426 related articles for article (PubMed ID: 21497747)
1. Anti-fibrogenic strategies and the regression of fibrosis.
Kisseleva T; Brenner DA
Best Pract Res Clin Gastroenterol; 2011 Apr; 25(2):305-17. PubMed ID: 21497747
[TBL] [Abstract][Full Text] [Related]
2. What's new in liver fibrosis? The origin of myofibroblasts in liver fibrosis.
Iwaisako K; Brenner DA; Kisseleva T
J Gastroenterol Hepatol; 2012 Mar; 27 Suppl 2(Suppl 2):65-8. PubMed ID: 22320919
[TBL] [Abstract][Full Text] [Related]
3. New therapies for hepatic fibrosis.
Koyama Y; Brenner DA
Clin Res Hepatol Gastroenterol; 2015 Sep; 39 Suppl 1(0 1):S75-9. PubMed ID: 26206573
[TBL] [Abstract][Full Text] [Related]
4. The characteristics of activated portal fibroblasts/myofibroblasts in liver fibrosis.
Karin D; Koyama Y; Brenner D; Kisseleva T
Differentiation; 2016 Sep; 92(3):84-92. PubMed ID: 27591095
[TBL] [Abstract][Full Text] [Related]
5. The origin of fibrogenic myofibroblasts in fibrotic liver.
Kisseleva T
Hepatology; 2017 Mar; 65(3):1039-1043. PubMed ID: 27859502
[TBL] [Abstract][Full Text] [Related]
6. Effect of human amniotic epithelial cells on pro-fibrogenic resident hepatic cells in a rat model of liver fibrosis.
Cargnoni A; Farigu S; Cotti Piccinelli E; Bonassi Signoroni P; Romele P; Vanosi G; Toschi I; Cesari V; Barros Sant'Anna L; Magatti M; Silini AR; Parolini O
J Cell Mol Med; 2018 Feb; 22(2):1202-1213. PubMed ID: 29105277
[TBL] [Abstract][Full Text] [Related]
7. Bone marrow cell transplantation is associated with fibrogenic cells apoptosis during hepatic regeneration in cholestatic rats.
Nunes de Carvalho S; da Cunha Lira D; Costa Cortez EA; de Andrade DC; Thole AA; Stumbo AC; de Carvalho L
Biochem Cell Biol; 2013 Apr; 91(2):88-94. PubMed ID: 23527637
[TBL] [Abstract][Full Text] [Related]
8. Recent advancement of molecular mechanisms of liver fibrosis.
Seki E; Brenner DA
J Hepatobiliary Pancreat Sci; 2015 Jul; 22(7):512-8. PubMed ID: 25869468
[TBL] [Abstract][Full Text] [Related]
9. The Origin and Fate of Liver Myofibroblasts.
Kim HY; Sakane S; Eguileor A; Carvalho Gontijo Weber R; Lee W; Liu X; Lam K; Ishizuka K; Rosenthal SB; Diggle K; Brenner DA; Kisseleva T
Cell Mol Gastroenterol Hepatol; 2024; 17(1):93-106. PubMed ID: 37743012
[TBL] [Abstract][Full Text] [Related]
10. Role of TGF-β signaling in differentiation of mesothelial cells to vitamin A-poor hepatic stellate cells in liver fibrosis.
Li Y; Lua I; French SW; Asahina K
Am J Physiol Gastrointest Liver Physiol; 2016 Feb; 310(4):G262-72. PubMed ID: 26702136
[TBL] [Abstract][Full Text] [Related]
11. Liver fibrogenic cells.
Forbes SJ; Parola M
Best Pract Res Clin Gastroenterol; 2011 Apr; 25(2):207-17. PubMed ID: 21497739
[TBL] [Abstract][Full Text] [Related]
12. Study on the relationship between hepatic fibrosis and epithelial-mesenchymal transition in intrahepatic cells.
Chen Y; Fan Y; Guo DY; Xu B; Shi XY; Li JT; Duan LF
Biomed Pharmacother; 2020 Sep; 129():110413. PubMed ID: 32570119
[TBL] [Abstract][Full Text] [Related]
13. New Developments on the Treatment of Liver Fibrosis.
Koyama Y; Xu J; Liu X; Brenner DA
Dig Dis; 2016; 34(5):589-96. PubMed ID: 27332862
[TBL] [Abstract][Full Text] [Related]
14. Liver fibrosis.
Bataller R; Brenner DA
J Clin Invest; 2005 Feb; 115(2):209-18. PubMed ID: 15690074
[TBL] [Abstract][Full Text] [Related]
15. Fibronectin extra domain-A promotes hepatic stellate cell motility but not differentiation into myofibroblasts.
Olsen AL; Sackey BK; Marcinkiewicz C; Boettiger D; Wells RG
Gastroenterology; 2012 Apr; 142(4):928-937.e3. PubMed ID: 22202457
[TBL] [Abstract][Full Text] [Related]
16. Hepatic toll-like receptor 4 expression is associated with portal inflammation and fibrosis in patients with NAFLD.
Vespasiani-Gentilucci U; Carotti S; Perrone G; Mazzarelli C; Galati G; Onetti-Muda A; Picardi A; Morini S
Liver Int; 2015 Feb; 35(2):569-81. PubMed ID: 24649857
[TBL] [Abstract][Full Text] [Related]
17. Role of NADPH oxidases in the redox biology of liver fibrosis.
Crosas-Molist E; Fabregat I
Redox Biol; 2015 Dec; 6():106-111. PubMed ID: 26204504
[TBL] [Abstract][Full Text] [Related]
18. Cellular mechanisms of tissue fibrosis. 5. Novel insights into liver fibrosis.
Mallat A; Lotersztajn S
Am J Physiol Cell Physiol; 2013 Oct; 305(8):C789-99. PubMed ID: 23903700
[TBL] [Abstract][Full Text] [Related]
19. Relaxin in hepatic fibrosis: What is known and where to head?
Ezhilarasan D
Biochimie; 2021 Aug; 187():144-151. PubMed ID: 34102254
[TBL] [Abstract][Full Text] [Related]
20. Hepatic fibrosis: It is time to go with hepatic stellate cell-specific therapeutic targets.
Ezhilarasan D; Sokal E; Najimi M
Hepatobiliary Pancreat Dis Int; 2018 Jun; 17(3):192-197. PubMed ID: 29709350
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
